Works matching IS 02780232 AND DT 2024 AND VI 42 AND IP 3


Results: 16
    1

    Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3277
    By:
    • Sciumè, Mariarita;
    • Serpenti, Fabio;
    • Zanotti, Roberta;
    • Bonadonna, Patrizia;
    • Tanasi, Ilaria;
    • Crosera, Lara;
    • Elena, Chiara;
    • Mannelli, Francesco;
    • Crupi, Francesca;
    • Papayannidis, Cristina;
    • Sartor, Chiara;
    • Soverini, Simona;
    • Rondoni, Michela;
    • Eller‐Vainicher, Cristina;
    • Pravettoni, Valerio;
    • Rivolta, Federica;
    • Alberti Violetti, Silvia;
    • Croci, Giorgio Alberto;
    • Migliorini, Anna Chiara;
    • Bolli, Niccolò
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Retraction.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3276
    Publication type:
    Article
    10

    A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3274
    By:
    • Manda, Sudhir;
    • Anz, Bertrand M.;
    • Benton, Christopher;
    • Broun, E. Randolph;
    • Yimer, Habte A.;
    • Renshaw, John S.;
    • Geils, George;
    • Berdeja, Jesus;
    • Cruz, Jose;
    • Melear, Jason M.;
    • Fanning, Suzanne;
    • Fletcher, Luke;
    • Li, Yukun;
    • Duan, Yinghui;
    • Werner, Michael E.;
    • Potluri, Jalaja;
    • Pai, Madhavi V.;
    • Donnellan, William B.
    Publication type:
    Article
    12

    Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203

    Published in:
    Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3272
    By:
    • Watanabe, Takashi;
    • Matsuno, Yoshihiro;
    • Wakabayashi, Masashi;
    • Maruyama, Dai;
    • Yamamoto, Kazuhito;
    • Kubota, Nobuko;
    • Shimada, Kazuyuki;
    • Asagoe, Kohsuke;
    • Yamaguchi, Motoko;
    • Ando, Kiyoshi;
    • Ogura, Michinori;
    • Kuroda, Junya;
    • Suehiro, Youko;
    • Tsukasaki, Kunihiro;
    • Tobinai, Kensei;
    • Nagai, Hirokazu
    Publication type:
    Article
    13
    14

    Issue Information.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3179
    Publication type:
    Article
    15
    16